Caption Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Caption Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-65,287	Closed	-$2.28M	–	1603
2024 Q1	$2.28M	Sell	65,287 -29,713	-31%	-$1.08M	0.03%	502
2023 Q4	$3.61M	Buy	+95,000	New	+$2.04M	0.05%	444
2023 Q1	–	Sell	-27,205	Closed	-$633K	–	1729
2022 Q4	$670K	Buy	+27,205	New	+$800K	0.01%	859

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Caption Management's INBX Position: Q2 2024 in Review

Caption Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 65,287 shares — an estimated $2.28M sold.

Caption Management first reported a position in INBX in Q4 2022 and held it in 3 quarters. The position peaked at $3.61M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Caption Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Caption Management sold 65,287 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.28M.
Caption Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Caption Management's Inhibrx, Inc. Common Stock position peaked at $3.61M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.